| Consistency | Direct and indirect evidence should agree. Tested globally (Q decomposition) and locally (node-splitting). |
| P-score | Frequentist analogue of SUCRA. Ranges 0-1; higher = more likely to be best. Should be reported alongside effect estimates, not used alone for ranking. |
| League table | Matrix of all pairwise comparisons. Read as row vs column. Colored by significance. |
| Prediction Interval | Shows where the true effect in a new study setting might fall. Uses t-distribution with df = k_designs - T + 1 and adds tau-squared to the variance. |
| Net Heat Plot | Matrix heatmap showing how each design (direct comparison) contributes to each NMA estimate. Warm colors = high contribution. Red borders = inconsistency hotspots (Krahn et al. 2013, BMC Med Res Meth). |
| Contribution Matrix | Percentage table: how much each direct comparison drives each NMA estimate. Based on the hat matrix approach (Papakonstantinou et al. 2018, Stat Med). |
| SIDE Test | Separating Indirect from Direct Evidence. Proper node-splitting test (Koenig et al. 2013): z-test comparing direct and indirect estimates. |
| Comparison-Adjusted Funnel | Residuals (study effect minus NMA estimate) plotted against SE. Asymmetry suggests small-study effects (Chaimani & Salanti 2012). |
| CINeMA | Confidence in NMA estimates across 6 domains: within-study bias, reporting bias, indirectness, imprecision, heterogeneity, incoherence (Nikolakopoulou et al. 2020). |
| Rank Robustness | Leave-one-out stability: what proportion of study removals preserve the ranking order for each treatment pair. |
| Design-by-Treatment | Global inconsistency test (Higgins et al. 2012): decomposes Q into heterogeneity and inconsistency components. Omnibus test complementing local node-splitting. |
| Rankogram | Proper simulation-based rankogram (Salanti et al. 2011): 1000 MVN samples from (beta, vcov), computing rank probabilities as heatmap. Reports mean rank and 95% CrI. |
| SUCRA | Surface Under Cumulative Ranking: SUCRA_i = sum(P(rank ≤ r)) / (T-1). Frequentist analogue should closely match P-scores. Computed from rankogram simulations. |
| Small-Study Effects | Comparison-adjusted Egger-like regression (Chaimani & Salanti 2012): tests slope of residuals vs SE. Adapted for NMA with comparison indicators. |
| Transitivity | Assessment table comparing study characteristics (precision, count, year proxy) across direct comparisons to check the fundamental NMA assumption. |
| Direct vs NMA | Split forest plot showing direct, network, and indirect estimates side-by-side for each comparison with head-to-head evidence. |
| Bridge Edges | Network vulnerability: identifies edges whose removal disconnects the network. Critical comparisons that the entire indirect evidence chain depends on. |
| Living NMA | Add new trials and re-analyze to track how network estimates evolve over time. |
| Pairwise MA | Standard pairwise random-effects MA for each direct comparison with 2+ studies. Reports pooled direct estimate, CI, I-squared, tau-squared, and compares with NMA estimate. |
| Het Decomposition | Compares common tau-squared model with comparison-specific tau-squared. Flags comparisons with tau-squared exceeding 2x the common value. |
| Information Fraction | For each NMA estimate, computes the percentage of information from direct vs indirect evidence. Stacked bar chart visualization. Flags comparisons with less than 20% direct evidence. |
| Network Meta-Regression | Extends NMA with a study-level covariate. Reports covariate effect and proportion of heterogeneity explained. Useful for assessing treatment effect modification. |
| Bayesian NMA | Monte Carlo approximation with Normal(0,100) priors for effects and Half-Normal(0,1) for tau. 5000 draws with seeded PRNG. Compares posterior medians and CrI with frequentist estimates. |
| All Pairs Forest | Forest plot of all T(T-1)/2 pairwise NMA comparisons, sorted by effect size. Shows diamonds and CI bars for every comparison. |
| Effect Surface | 2D scatter of treatments: effect vs reference on X, precision on Y. Confidence ellipses show estimation uncertainty. Visualizes treatment clustering. |